Molecular tumor boards improve outcomes for patients with advanced cancer
In a recent University of Kentucky Markey Cancer Center clinical trial, patients with advanced cancer experienced improved outcomes when their treatments were directed by a molecular tumor board.
Sep 22, 2022
0
18